in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Glenmark Buys Czech Pharma Firm
12:25 PM MDT | July 26, 2007 | DR
Glenmark Pharmaceuticals Ltd.’s (Mumbai) subsidiary Glenmark Holdings (GHSA; La Chaux-de-Fonds, Switzerland) says it has acquired more than a 90% stake in Czech pharmaceutical company Medicamenta (Praha). Terms were not disclosed. Medicamenta’s 2007 projected revenue is $8 million, Glenmark says. Medicamenta has sales and marketing operations in the Czech Republic and Slovakia, and the deal gives Glenmark an entry point into those fast-growing regions, Glenmark says. The transaction is part of Glenmark’s long-term strategy to “emerge as a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee